Long-term use of common anti-acid medications, known as proton pump inhibitors (PPIs), may not increase the risk of stomach cancer, a new study suggests, potentially offering reassurance to millions of patients.
These widely prescribed drugs treat conditions like acid reflux and ulcers, but have been subject to cancer fears since their introduction in the 1980s, with some previous research indicating a link.
